From: Retrospective analysis of the diagnostic yield of newborn drug testing
Results of meconium testing | ||||
---|---|---|---|---|
Group A | Group B | Group C | Group D | |
No drug(s) or metabolite(s) detected1(n = 1,916) | All findings explained by prescribed medication(s) (n = 283) | Non-medical drug use detected2(n = 229) | Unexplained drug(s) or metabolite(s) detected (n = 69) | |
Maternal age (years) 3 | 26 (10) | 27 (9) | 26 (7) | 26 (8) |
Gestational age (weeks) 3 | 38 (5.2) | 35.9 (7.6) | 38 (5.3) | 36.7 (7) |
Gravida 3 | 2 (3) | 2 (2) | 3 (3) | 3 (2) |
Para 3 | 1 (2) | 1 (1) | 2 (2) | 2 (2) |
Days meconium collected after birth 3 | 0 (1) | 1 (6) | 0 (1) | 1 (2) |
Health insurance Status | ||||
Private insurance | 31.0% | 30.7% | 12.7% | 31.9% |
Student insurance | 1.0% | 0.7% | 0.0% | 0.0% |
Medicaid | 47.5% | 42.4% | 63.3% | 47.8% |
Uninsured | 20.0% | 25.8% | 24.0% | 20.3% |
Self-Declared Race | ||||
Caucasian | 77.0% | 72.4% | 61.6% | 75.4% |
African-American | 9.0% | 9.5% | 27.9% | 10.1% |
Hispanic | 9.0% | 6.0% | 1.3% | 5.8% |
Native American | 1.0% | 1.8% | 0.9% | 0.0% |
Mixed race | 0.5% | 1.4% | 3.9% | 2.9% |
Asian/Pacific Islander | 1.5% | 1.4% | 0.0% | 0.0% |
Unknown race | 2.0% | 7.4% | 4.4% | 5.8% |